Gangqin Li

Title: Gangqin Li: Innovator in Hepatitis B Treatment

Introduction

Gangqin Li is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for hepatitis B virus infection. With a total of 2 patents, his work showcases innovative approaches to combating viral infections.

Latest Patents

Gangqin Li's latest patents include the invention of 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection. This invention provides novel compounds characterized by a specific general formula, which includes various forms such as pharmaceutically acceptable salts, tautomeric isomers, enantiomers, and diastereomers. The invention also encompasses compositions that include these compounds and methods for their use.

Career Highlights

Throughout his career, Gangqin Li has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Some of his notable coworkers include Lei Guo and Taishan Hu. Their collaboration has likely played a role in advancing the research and development of new therapeutic compounds.

Conclusion

Gangqin Li's contributions to the field of hepatitis B treatment through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.